BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
 
 

Synoptics Opens New US Facility - To Provide Outstanding Sales and Service Support

Cambridge, UK: Synoptics, a world leader in the development and manufacture of innovative digital imaging systems for scientific applications, is delighted to announce its new US headquarters in Frederick, MD is fully operational. This Synoptics Inc. facility will cater exclusively for Synoptics’ US customers, making it quicker and easier for them to access information and assistance on the company’s superb product range.

 Highly skilled technical staff, specially trained to support each of Synoptics’ distinct divisions, Syngene, Synbiosis and Syncroscopy are now manning the new offices and workshops. Syngene,; the largest division, one produces powerful systems for analysis and documentation of information from DNA and protein gels. Syncroscopy and Synbiosis’s expertise lies in providing imaging solutions for microscopy and microbial applications respectively.

 As well as having a complete sales and marketing support team, Synoptics Inc. has a fully equipped workshop with expert personnel trained to service and repair all Synoptics’ systems. The company also has a team of service engineers, on call to repair and service Synoptics’ equipment in user’s laboratories anywhere in the US.

 Paul Ellwood, President of Synoptics Inc. stated: “We are investing very heavily in ensuring that our sales and support team in the US is every bit as professional and skilled as our European team. In fact, our commitment is so serious to our US customers that over a third of the Synoptics’ workforce is now based in the US and we intend to keep expanding here to meet customer needs.”

“We feel the time is right for us to forge better links with our US customers and they will benefit tremendously from having closer and more personal contact. It will give them the confidence to try our outstanding imaging systems, many of which are the finest in the world, safe in the knowledge that they will be guided every step of the way,” concluded Mr Ellwood.

-Ends-


For Further Information Contact:

Jayne Arthur, Synoptics Ltd, Beacon House, Nuffield Road, Cambridge, CB4 1TF, UK.

Tel: +44(0) 1223-727100 Fax +44 (0) 1223-727101

Email: jayne.arthur@synoptics.co.uk Web site: www.synoptics.co.uk

Editor Contact:

Dr Sue Pearson, PO Box 170, Hitchin, Hertfordshire SG5 3GD, UK.

Tel/Fax: + 44(0) 1462- 635327 Email: sue6.pearson@ntlworld.com

Note to Editors

About Synoptics

Synoptics based in Cambridge, UK is a world-leader in the development and manufacture of innovative digital imaging systems for a range of scientific applications. The Company has three divisions, Syngene, Syncroscopy and Synbiosis of which Syngene is the largest.

Syngene produces advanced systems for molecular biologists to analyse and document information from gels. Synoptics’ other divisions, Syncroscopy and Synbiosis, specialise in digital imaging solutions for microscopy and microbial applications respectively. The Company founded in 1985 currently employs 55 people, 15 of whom are based at Synoptics Inc. in the USA. It has profitable revenue of over $10 million and continues to grow rapidly.

 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.